Concepedia

Umeclidinium/Vilanterol: First Global Approval

Lesley J. Scott, Philip I Hair

Drugs · 2014 · 17 citations · 4 references

DOI

Concepts

References

4

In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action

Robert J. Slack, Victoria J. Barrett, Valerie S. Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 111 citations

, , +14

Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases

M Salmon, Mark A. Luttmann, James J. Foley et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 79 citations

, , +16

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial

Dennis Kelleher, Rashmi Mehta, Bernadette Jean-Francois et al. · PLoS ONE · 2012 · 43 citations · Full text

, , +17

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study

Rashmi Mehta, Kelleher, Andrew Preece et al. · International Journal of COPD · 2013 · 34 citations · Full text

, , +17